Social Media Content Creators Fueling Unofficial Trade for Unlicensed Weight-Loss Medication
An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.
Some professionals stated the demand for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.
Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or imprisonment.
Service Reaction and Material Removal
According to TikTok, the platform has taken down problematic content and banned related keywords and search suggestions. The organization said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Investigations also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with images of weight loss, glowing testimonials and detailed instructions for mixing or injecting at home.
Within moments of joining one community, a vendor posted WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.
Item Information and Pricing
Within these communities, messages show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how much time a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram said it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has already seen individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly significant medical dangers”.